Michael R. Eber

583 total citations
11 papers, 431 citations indexed

About

Michael R. Eber is a scholar working on Epidemiology, Economics and Econometrics and Infectious Diseases. According to data from OpenAlex, Michael R. Eber has authored 11 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Economics and Econometrics and 3 papers in Infectious Diseases. Recurrent topics in Michael R. Eber's work include Urinary Tract Infections Management (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Antibiotic Use and Resistance (3 papers). Michael R. Eber is often cited by papers focused on Urinary Tract Infections Management (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Antibiotic Use and Resistance (3 papers). Michael R. Eber collaborates with scholars based in United States, India and France. Michael R. Eber's co-authors include Ramanan Laxminarayan, Marin L. Schweizer, Eli N. Perencevich, Michelle Shardell, Nikolay Braykov, Eili Klein, Daniel J. Morgan, Marc Hoffmann, Kyle J. Popovich and Michael Rubin and has published in prestigious journals such as PLoS ONE, American Heart Journal and Risk Analysis.

In The Last Decade

Michael R. Eber

11 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael R. Eber United States	7	137	133	100	79	58	11	431
Emese Szilágyi Hungary	11	195 1.4×	109 0.8×	138 1.4×	107 1.4×	93 1.6×	13	420
Soad Hafez Egypt	10	221 1.6×	152 1.1×	191 1.9×	93 1.2×	81 1.4×	15	512
Maria Roumbelaki Greece	11	137 1.0×	108 0.8×	128 1.3×	107 1.4×	68 1.2×	12	378
Vesna Šuljagić Serbia	9	158 1.2×	110 0.8×	89 0.9×	85 1.1×	45 0.8×	41	451
Le‐Yin Hsu Taiwan	12	199 1.5×	99 0.7×	99 1.0×	116 1.5×	44 0.8×	36	558
Francesco M. Labricciosa Italy	10	83 0.6×	108 0.8×	172 1.7×	84 1.1×	38 0.7×	17	480
Garyphalia Poulakou Greece	12	156 1.1×	213 1.6×	92 0.9×	111 1.4×	44 0.8×	16	566
Laura Gavaldà Spain	15	159 1.2×	100 0.8×	101 1.0×	170 2.2×	84 1.4×	22	533
Min Hyok Jeon South Korea	15	151 1.1×	193 1.5×	98 1.0×	123 1.6×	35 0.6×	47	504
Kate McCarthy Australia	14	117 0.9×	183 1.4×	64 0.6×	97 1.2×	46 0.8×	54	617

Countries citing papers authored by Michael R. Eber

Since Specialization

Citations

This map shows the geographic impact of Michael R. Eber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Eber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Eber more than expected).

Fields of papers citing papers by Michael R. Eber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Eber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Eber. The network helps show where Michael R. Eber may publish in the future.

Co-authorship network of co-authors of Michael R. Eber

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Eber. A scholar is included among the top collaborators of Michael R. Eber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Eber. Michael R. Eber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Ferranna, Maddalena, Lisa A. Robinson, Daniel Cadarette, Michael R. Eber, & David E. Bloom. (2023). The benefits and costs of U.S. employer COVID‐19 vaccine mandates. Risk Analysis. 43(10). 2053–2068. 4 indexed citations

Robinson, Lisa A., Michael R. Eber, & James K. Hammitt. (2022). Valuing COVID-19 Morbidity Risk Reductions. Journal of Benefit-Cost Analysis. 13(2). 247–268. 6 indexed citations

Eber, Michael R., Cass R. Sunstein, James K. Hammitt, & Jennifer M. Yeh. (2021). The modest effects of fact boxes on cancer screening. Journal of Risk and Uncertainty. 62(1). 29–54. 3 indexed citations

Eber, Michael R., Dana P. Goldman, Darius Lakdawalla, et al.. (2015). Clinical evidence inputs to comparative effectiveness research could impact the development of novel treatments. Journal of Comparative Effectiveness Research. 4(3). 203–213. 2 indexed citations

Schweizer, Marin L., Eli N. Perencevich, Michael R. Eber, et al.. (2013). Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections. Antimicrobial Resistance and Infection Control. 2(1). 28–28. 6 indexed citations

Braykov, Nikolay, Michael R. Eber, Eili Klein, Daniel J. Morgan, & Ramanan Laxminarayan. (2013). Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999–2010. Infection Control and Hospital Epidemiology. 34(3). 259–268. 69 indexed citations

Turakhia, Mintu P., Matthew D. Solomon, Mehul Jhaveri, et al.. (2013). Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation. American Heart Journal. 166(3). 573–580. 17 indexed citations

Schweizer, Marin L., Michael R. Eber, Ramanan Laxminarayan, et al.. (2011). Validity of ICD-9-CM Coding for Identifying Incident Methicillin-Resistant Staphylococcus aureus (MRSA) Infections: Is MRSA Infection Coded as a Chronic Disease?. Infection Control and Hospital Epidemiology. 32(2). 148–154. 37 indexed citations

Eber, Michael R., Michelle Shardell, Marin L. Schweizer, Ramanan Laxminarayan, & Eli N. Perencevich. (2011). Seasonal and Temperature-Associated Increases in Gram-Negative Bacterial Bloodstream Infections among Hospitalized Patients. PLoS ONE. 6(9). e25298–e25298. 126 indexed citations

10.

Eber, Michael R.. (2010). Clinical and Economic Outcomes Attributable to Health Care–Associated Sepsis and Pneumonia. Archives of Internal Medicine. 170(4). 347–347. 137 indexed citations

11.

Hoffmann, Marc, Michael R. Eber, & Ramanan Laxminarayan. (2009). Increasing Resistance of Acinetobacter Species to Imipenem in United States Hospitals, 1999–2006. Infection Control and Hospital Epidemiology. 31(2). 196–197. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact